Levocetirizin Stada (Levocetirizine Dihydrochloride)

Levocetirizine is a selective antagonist of peripheral H1 histamine receptors. It prevents histamine released during allergic reactions from binding to these receptors, thereby inhibiting the cascade that leads to vasodilation, increased vascular permeability, and sensory nerve activation. This results in decreased inflammation and relief of allergy‑related symptoms.

The appropriate dose of Levocetirizin Stada is determined by the prescribing healthcare professional based on the patient’s age, renal function, and severity of symptoms. Dosage recommendations are provided in the product labeling, and the prescriber will tailor the regimen to each individual’s clinical needs.

Safety data for levocetirizine in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and this decision must be made by a qualified healthcare provider after a thorough risk‑benefit assessment.

To request Levocetirizin Stada, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Levocetirizin Stada is the active enantiomer of cetirizine, offering a more selective H1‑receptor blockade and often a lower incidence of sedation compared with first‑generation antihistamines. Compared with other second‑generation agents, its efficacy in allergic rhinitis and urticaria is comparable, while its safety profile remains favorable for most patients.

Levocetirizin Stada should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keeping the product in a dry, cool place helps maintain its potency and ensures the tablet’s integrity throughout its shelf life.

Levocetirizin Stada is taken orally, usually as a tablet, with or without food. The tablet should be swallowed whole with a glass of water. Patients should follow the dosing instructions provided by their prescriber and not alter the regimen without medical advice.

While generally well tolerated, serious adverse events can include angioedema, severe skin reactions such as Stevens‑Johnson syndrome, anaphylaxis, thrombocytopenia, and hepatic dysfunction. Patients should seek immediate medical attention if they experience swelling of the face or throat, rash, or any signs of an allergic emergency.

Levocetirizin Stada is contraindicated in individuals with known hypersensitivity to levocetirizine or any of the tablet’s excipients. Caution is advised for patients with severe renal impairment, and it should be avoided in pregnancy or lactation unless clearly indicated by a healthcare professional.